Tentt

Lilly to Acquire Centessa for Sleep-Wake Disorders

Announced
HealthcareMerger

Deal Overview

Lilly agreed to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders. The deal is described as a merger.

The excerpt provided does not include consideration, valuation, or timing details, but the stated strategic focus is developing therapies for sleep-wake disorder indications.

Key Details

Transaction
Lilly acquires Centessa Pharmaceuticals
Deal Size
Over $100M

Filed under

Source

Read full article on prnewswire.com

via GN - entered into definitive agreement · April 1, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →